搜尋結果
Citi names 3 biotech stocks to play a growing $2.9 billion opportunity — giving one about 50% upside
CNBC· 3 日前The outlook is starting to look bright for biotech stocks, according to some. With markets now ...
Midi is building a digital platform for an oft-overlooked area of women's health
TechCrunch· 3 日前When Joanna Strober was around 47, she stopped sleeping. While losing sleep is a common symptom of perimenopause, she first ...
The 9 Best Cellulite Creams, According To A Plastic Surgeon
Forbes· 3 日前Topical products may not solve certain skin woes, but for some concerns active ingredients, ...
This Could Kill The iPhone Notch, Bring Cheap FaceID To Android, And Medical Apps To Your Camera
Forbes· 3 日前Own an iPhone? You probably have a notch at the top of your screen, just like your iPad, and ...
The Tech Wrangler: Cameraphones Compared In Antarctica
Forbes· 3 日前The Tech Wrangler is a monthly column in which Forbes Vetted contributors and staff members explore the best values in consumer ...
Atletico Madrid hit with two-match partial stand closure after racist abuse
Reuters· 3 日前Atletico Madrid have been ordered to partially close their south stand for two matches by the ...
This Soothing Eye Cream Makes Me Look Well-Rested (Even When I’m Up Before Dawn)
The Wall Street Journal· 3 日前My eyes had barely opened but I was already zipping up my bulky puffer coat to face the chill ...
Incyte misses quarterly profit on weak sales of lead drug
Reuters· 3 日前, opens new tab on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug ...
What is Ozempic face and how can you avoid it?
South China Morning Post· 3 日前Known generically as semaglutide, Ozempic is a drug that works to treat type 2 diabetic ...
L'Occitane's billionaire owner Geiger to take firm private in $1.8 bln deal
Reuters· 4 日前, opens new tab chairman and controlling shareholder, Reinold Geiger, will take the skin-care ...